← All indications
Anorexia Nervosa
An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; and refusal to maintain minimal normal weight.
Drugs by status
Approved for this indication (2)
Phase 4 trials (2)
Phase 3 trials (14)
Phase 2 trials (11)
Phase 1 trials (5)
Organizations
Organization Involved with Phase 4 Indications (11)
Organization Involved with Phase 3 Indications (16)
- Novo Nordisk
- BioGaia AB
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Harvard University
- University of Ottawa
- University of Southern Denmark
- University of Zagreb
- University of Zurich
- Department of Defense
- University of Montpellier
- University of Lille
- University of Barcelona
- University of Nantes
- University of Paris
- Rouen Normandy University
Organization Involved with Phase 2 Indications (12)
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (11)